Ftse Mib
33.645,43
-0,27%
DAX
18.001,60
0,54%
S&P 500
5.127,79
1,26%
NASDAQ
16.156,33
1,99%
Bitcoin
62.829,38
6,27%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Aldeyra Therapeutics Inc (ALDX) Aldeyra Therapeutics Inc (ALDX) Notizie

Aldeyra Therapeutics Inc

ALDX
4,16
-0,05 (-1,19%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:28:45
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
25/4/202413:00BWAldeyra Therapeutics Highlights Recent Preclinical Data in..
18/4/202413:00BWAldeyra Therapeutics to Host Research & Development Day on..
28/3/202412:00BWAldeyra Therapeutics Announces Clinical Development Plan for..
07/3/202422:54EDGAR2Form S-3 - Registration statement under Securities Act of..
07/3/202422:48EDGAR2Form S-8 - Securities to be offered to employees in employee..
07/3/202422:40EDGAR2Form S-8 POS - Securities to be offered to employees in..
07/3/202422:06EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
06/2/202413:00BWAldeyra Therapeutics to Participate in the Oppenheimer 34th..
29/1/202423:25EDGAR2Form SC 13G - Statement of acquisition of beneficial..
04/1/202413:00EDGAR2Form 8-K - Current report
04/1/202413:00BWAldeyra Therapeutics Provides Clinical and Regulatory Update..
21/12/202322:06EDGAR2Form 8-K - Current report
19/12/202313:05EDGAR2Form 8-K - Current report
19/12/202313:00BWAldeyra Therapeutics Announces Statistically and Clinically..
18/12/202322:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
28/11/202313:16EDGAR2Form 8-K - Current report
27/11/202322:07BWAldeyra Therapeutics Receives Complete Response Letter from..
03/11/202321:43EDGAR2Form S-8 - Securities to be offered to employees in employee..
03/11/202321:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
01/11/202312:09EDGAR2Form 8-K - Current report
01/11/202312:05BWAldeyra Therapeutics Enters into Exclusive Option Agreement..
16/10/202314:00EDGAR2Form 8-K - Current report
27/9/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
26/9/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
19/9/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
12/9/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
11/9/202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/8/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
24/8/202322:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/8/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
16/8/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
11/8/202311:45PRNUSALDX SHAREHOLDER ALERT: Jakubowitz Law Reminds Aldeyra..
09/8/202311:45PRNUSSHAREHOLDER ALERT: The Gross Law Firm Notifies Shareholders..
04/8/202311:45PRNUSALDX SHAREHOLDER ALERT: Jakubowitz Law Reminds Aldeyra..
03/8/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/7/202313:00BWAldeyra Therapeutics to Participate in SVB Securities..
05/7/202323:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202323:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/7/202323:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/7/202322:07EDGAR2Form 8-K - Current report
29/6/202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/6/202313:01EDGAR2Form 8-K - Current report
29/6/202313:00BWAldeyra Therapeutics Announces Improvement from Baseline in..
28/6/202322:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
27/6/202313:00BWAldeyra Therapeutics Announces Statistically Significant..
26/6/202322:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
23/6/202313:00BWAldeyra Therapeutics to Join the Russell 2000® and Russell..
21/6/202315:34BWAldeyra Therapeutics Provides Regulatory Update on ADX-2191
15/6/202313:00BWAldeyra Therapeutics Announces Achievement of Statistical..
14/6/202322:01BWAldeyra Therapeutics Schedules Conference Call and Webcast..
Apertura: 4,23 Min: 4,075 Max: 4,29
Chiusura: 4,21

La tua Cronologia

NASDAQ
ALDX
Aldeyra Therapeutics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network